Connect with us

Hi, what are you looking for?

Editor's Pick

House ethics panel launches investigation of Rep. Sheila Cherfilus-McCormick

A House Ethics panel announced Wednesday that it will investigate whether Rep. Sheila Cherfilus-McCormick (D-Fla.) violated campaign finance laws and failed to file required disclosure forms last year as she ran in a special election for her seat and sought reelection months later.

A statement from the top Republican and Democrat on the House Ethics Committee said that the panel had voted unanimously to create an investigative subcommittee to examine allegations that the congresswoman “may have violated campaign finance laws and regulations in connection with her 2022 special election and/or 2022 reelection campaigns; failed to properly disclose required information on statements required to be filed with the House; and/or accepted voluntary services for official work from an individual not employed in her congressional office.”

The statement provided no specifics on the allegations.

Cherfilus-McCormick’s press secretary, Jonathan Levin, emphasized in a statement that “the mere fact of establishing an investigative subcommittee does not itself indicate that any violation occurred.”

“Regardless, the Congresswoman takes these matters seriously and is working to resolve them,” he said.

Cherfilus-McCormick was elected to represent Florida’s 20th Congressional District, one of the most Democratic-leaning districts in the state, in early 2022 as part of a special election to replace the late Rep. Alcee L. Hastings (D-Fla.). She was reelected later that year.

Cherfilus-McCormick has faced scrutiny over how she financed her campaigns.

In 2022, the Sun Sentinel highlighted that she began self-funding her congressional campaign in 2021 just as the health-care company where she was chief executive started receiving roughly $8 million in contracts for providing coronavirus vaccines to underserved communities.

Cherfilus-McCormick loaned her campaign millions and also reported a major jump in her income — going from reporting $86,000 in 2020 to $6.4 million in 2021, according to the Sun Sentinel. Cherfilus-McCormick’s largest source of income in 2021 — $5.7 million — came from an LLC connected to her work as a health-care CEO.

The subcommittee investigating the issue is composed of four members: Reps. Andrew R. Garbarino (R-N.Y.), Chrissy Houlahan (D-Pa.), Cliff Bentz (R-Ore.) and Troy A. Carter (D-La.).

This post appeared first on The Washington Post

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    North Korea may be known as the hermit kingdom, but the isolated nation could be edging toward opening its borders to small numbers of...

    Editor's Pick

    One of the perks of being speaker of the House — or at least, one of the characteristics of it — is that you...

    Latest News

    Evacuations are underway across Hawaii’s Big Island and Maui as passing Hurricane Dora helps fuel wildfires that have damaged structures, prompted rescues and spurred...

    Latest News

    Former world No. 1 Caroline Wozniacki won her first competitive tennis match in three-and-a-half years on Tuesday, defeating Australian Kimberly Birrell 6-2 6-2 at...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024